Latest News about CYTK
Recent news which mentions CYTK
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
September 07, 2022
From Benzinga
From Benzinga
Cytokinetics Records $89M Q2 Sales On Deferred Mavacamten Revenues, Forecasts FY22 Cash Of Over $800M
August 05, 2022
Tickers
CYTK
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Monday
May 16, 2022
From Benzinga
70 Biggest Movers From Friday
May 02, 2022
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
April 29, 2022
From Benzinga
Cytokinetics's Omecamtiv Mecarbil Shows No Effect On Exercise Capacity In Heart Failure Patients
April 04, 2022
Tickers
CYTK
From Benzinga
From Benzinga
56 Biggest Movers From Friday
January 10, 2022
From Benzinga
33 Stocks Moving In Friday's Mid-Day Session
January 07, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021
December 22, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
December 10, 2021
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
A bargain you can’t ignore: Small-cap stocks are trading at their second-lowest discount in 20 years
November 04, 2021
From MarketWatch
Cytokinetics, Incorporated (CYTK) Q3 2021 Earnings Call Transcript
November 04, 2021
Tickers
CYTK
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.